Skip to content
BY 4.0 license Open Access Published by De Gruyter Open Access April 26, 2020

Large Brunner’s gland adenoma of the duodenum for almost 10 years

  • Bo Yang , Ke Li , Runlan Luo , Zuming Xiong , Lianwei Wang , Jinming Xu and Dengyang Fang EMAIL logo
From the journal Open Life Sciences

Abstract

Background

Brunner’s gland adenoma is a rare benign tumor arising from Brunner’s glands. It is mostly small in size, and patients with this tumor are asymptomatic.

Case presentation

We report the case of a 63-year-old woman with upper gastrointestinal obstruction for almost 10 years, who was pathologically diagnosed with large Brunner’s gland adenoma of the duodenum. Postoperatively, no sign of recurrence has been noted until now.

Conclusion

This study may help clinicians to understand and provide a more accurate diagnosis of Brunner’s gland adenoma.

1 Introduction

Johan Conrad Brunner, a Swedish anatomist, first described Brunner’s glands in 1688. However, Brunner’s gland adenoma, also called polypoid hamartoma or Brunneroma, was first described by Curveilheir in 1835. It is a rare benign tumor arising from Brunner’s glands that may be transformed into a malignant tumor [1,2,3] and is mostly small in size. Patients with this tumor are asymptomatic. Occasionally, it may be large in size, which may cause hemorrhage or obstruction. Herein, we report the case of a patient who had large Brunner’s gland adenoma of the duodenum with upper gastrointestinal obstruction for almost 10 years and review the literature extensively.

2 Case report

A 63-year-old woman came to our hospital complaining of recurrent upper abdominal fullness discomfort for almost 10 years. She experienced exacerbation of intermittent nausea, vomiting with chyme (5 mL), heartburn, acid regurgitation, and eructation for 6 months. No history of hypertension, diabetes mellitus, or coronary heart disease was noted. Upon physical examination, a 5 × 4 cm mass with a hard texture and poor mobility was observed in the upper abdomen. Routine blood and tumor marker test results were within normal range. Abdomen computed tomography (CT, Figure 1A) showed a 32 mm × 22 mm soft tissue mass shadow with homogeneous density in the descending duodenum, which was protruding into the duodenal lumen. Moreover, thickening of the adjacent intestinal wall was noted. Upper abdomen magnetic resonance imaging (MRI, Figure 1B) revealed a significant thickening of the wall of the duodenal bulb and descending duodenum. The wall thickness was 1.1 cm. The signals were slightly low in T1-weighted images and slightly high in T2-weighted images. Endoscopic ultrasonography (Figure 1C and D) demonstrated that there was a protrusion in the duodenal bulb of about 26 × 18 mm in size with a clear boundary, smooth surface, and irregular shape and the base being about 17 mm, color signals abound.

Figure 1 The abdomen CT (A), abdomen MRI (B), and endoscopic ultrasonography (C and D) of
                  Brunner’s gland adenoma in this case. (A) Implied a uniform soft tissue
                  mass shadow in the descending duodenum. (B) Revealed a significant thickening of
                  the wall of the duodenal bulb and descending duodenum. (C and D) Demonstrated that
                  there was a protrusion lesion with a clear boundary, smooth surface, and color
                  signals in bulb duodenum.
Figure 1

The abdomen CT (A), abdomen MRI (B), and endoscopic ultrasonography (C and D) of Brunner’s gland adenoma in this case. (A) Implied a uniform soft tissue mass shadow in the descending duodenum. (B) Revealed a significant thickening of the wall of the duodenal bulb and descending duodenum. (C and D) Demonstrated that there was a protrusion lesion with a clear boundary, smooth surface, and color signals in bulb duodenum.

Neoplasm resection of duodenum was performed, and we found a mass measuring about 25 × 30 × 10 mm located in the descending duodenum. It was soft, brittle, and mobile with a clear boundary. The pathological result (Figure 2) of the mass revealed multiple Brunner’s glands with tubes, fibers, and smooth muscle diffuse distribution. No dysplasia was noted on the epithelium. It was diagnosed as Brunner’s gland adenoma of the duodenum. The patient was discharged from the hospital a week after recovery. To date, no relapse has occurred.

Figure 2 The pathology of this case. It revealed multiple Brunner’s glands with
                  tubes, fibers, and smooth muscle diffuse distribution.
Figure 2

The pathology of this case. It revealed multiple Brunner’s glands with tubes, fibers, and smooth muscle diffuse distribution.

  1. Informed consent: Informed consent has been obtained from the patient included in this study.

3 Discussion

Brunner’s gland adenoma is primarily located in the duodenum, especially the proximal duodenum, and is possibly caused by hyperplasia of the secretory tubes and stroma in the proximal duodenum [4,5]. Brunner’s gland could be classified into three types based on its size [6]: type I (diffuse nodular hyperplasia), which is confined to the mucosa with multiple sessile projections occupying most of the duodenum; type II (circumscript nodular hyperplasia), which is found in the bulb duodenum and is usually smaller than 1 cm; and type III (Brunner’s gland adenoma), which is usually stemmed and sized 1–2 cm, generally without clinical manifestations [7]. The etiology and pathophysiology of Brunner’s gland adenoma are unknown. The adenoma may be associated with increased acid secretion [8] or Helicobacter pylori infection [9]. It is reported that patients with chronic gastric erosion and duodenal ulcer are more prone to Brunner’s gland adenoma [10]. In our case, the patient suffered from chronic superficial gastritis. This is possibly a predisposing factor for Brunner’s gland adenoma, which usually occurs in individuals aged 50–60 years, without gender difference. Large Brunner’s gland adenomas of several centimeters in size are extremely rare [11] and may cause upper gastrointestinal hemorrhage and obstruction, vomiting, stomachache, diarrhea [12], anemia [13], acute pancreatitis, and obstructive jaundice [13,14]. In this report, we present the clinical findings of a patient who had a large Brunner’s gland adenoma in the upper abdomen for almost 10 years, which presented as upper gastrointestinal obstruction.

The accurate diagnosis of Brunner’s gland adenoma can be made through histopathological examination; however, such examination is difficult to perform preoperatively. Gastrointestinal endoscopy, CT, and other radiologic imaging methods are useful for identifying the cause of the clinical manifestations. Nonetheless, Brunner’s gland adenoma is easily confused with pancreaticoduodenal tumors because it is nonspecific, which may lead to difficulties in diagnosing and changes in the treatment strategy [15]. At present, surgical excision is the most effective treatment for Brunner’s gland adenoma. However, whether asymptomatic Brunner’s gland adenoma detected coincidentally should be excised or not is still unclear at present. Some studies demonstrate that treatment is not required, while others report that endoscopic or surgical resection is important in preventing the complications due to Brunner’s gland adenoma [16]. In our opinion, it is necessary to perform surgical or endoscopic resection because the tumor may cause serious complications, including acute hemorrhage and even shock in some cases [11]. Brunner’s gland adenoma is a benign tumor with a good prognosis. Some literature reviews demonstrate that a few of these tumors could be malignant [3], and therefore, warrant attention. In our study, a large Brunner’s gland adenoma of the duodenum with upper gastrointestinal obstruction for almost 10 years was noted. Postoperatively, no sign of recurrence has been noted.

4 Conclusion

Brunner’s gland adenoma is a rare benign tumor of the duodenum. It is also an insidious cause of upper gastrointestinal obstruction because some patients may present with upper gastrointestinal bleeding, and a few of these tumors could be malignant, and therefore, warrant attention. Endoscopic resection is the first treatment choice when the tumor is small or has a stem. Surgery is reserved for cases where endoscopic resection has failed or when the tumor is large.


Phone: +81 018875420508,

Acknowledgments

We appreciate the patient and her family members for their permission to report this case in this article.

  1. Conflict of interest: The authors state no conflict of interest.

References

[1] Fujimaki E, Nakamura S, Sugai T, Takeda Y. Brunner’s gland adenoma with a focus of p53-positive atypical glands. J Gastroenterol. 2000;35:155–8.10.1007/s005350050029Search in Google Scholar

[2] Matsui T, Iida M, Fujischima M, Sakamoto K, Watanabe H. Brunner’s gland hamartoma associated with microcarcinoids. Endoscopy. 1989;21:37–8. 10.1055/s-2007-1012891.Search in Google Scholar

[3] Brookes MJ, Manjunatha S, Allen CA, Cox M. Malignant potential in a Brunner’s gland hamartoma. Postgrad Med J. 2003;79:416–7.10.1136/pmj.79.933.416Search in Google Scholar

[4] Desa LA, Bridger J, Grace PA, Krausz T, Spencer J. Primary jejunoileal tumors: a review of 45 cases. World J Surg. 1991;15:81–6, discussion 86–7.10.1007/BF01658970Search in Google Scholar

[5] Zollinger Jr RM. Primary neoplasms of the small intestine. Am J Surg. 1986;151:654–8.10.1016/0002-9610(86)90035-8Search in Google Scholar

[6] Feyrter F. Uber wucherunger der Brunnerschen Drusen. Virchows Arch. 1938;509–26.10.1007/BF01888437Search in Google Scholar

[7] Chattopadhyay P, Kundu AK, Bhattacharyya S, Bandyopadhyay A. Diffuse nodular hyperplasia of Brunner’s gland presenting as upper gastrointestinal haemorrhage. Singap Med J. 2008;49:81–3.Search in Google Scholar

[8] Rocco A, Borriello P, Compare D, De Colibus P, Pica L, Iacono A, et al. Large Brunner’s gland adenoma: case report and literature review. World J Gastroenterol. 2006;12:1966–8.10.3748/wjg.v12.i12.1966Search in Google Scholar

[9] Kovacevic I, Ljubicic N, Cupic H, Doko M, Zovak M, Troskot B, et al. Helicobacter pylori infection in patients with Brunner’s gland adenoma. Acta Med Croat. 2001;55:157–60.Search in Google Scholar

[10] Franzin G, Musola R, Ghidini O, Manfrini C, Fratton A. Nodular hyperplasia of Brunner’s glands. Gastrointest Endosc. 1985;31:374–8.10.1016/S0016-5107(85)72251-1Search in Google Scholar

[11] Levine JA, Burgart LJ, Batts KP, Wang KK. Brunner’s gland hamartomas: clinical presentation and pathological features of 27 cases. Am J Gastroenterol. 1995;90:290–4.Search in Google Scholar

[12] Fuse Y, Tsuchihashi Y, Takamasu M, Kawamoto K, Kodama T, Fujita S, et al. Thickness of Brunner’s glands and its clinical significance in peptic ulcer diseases. Gastroenterol Jpn. 1989;24:512–8.10.1007/BF02773877Search in Google Scholar PubMed

[13] Iusco D, Roncoroni L, Violi V, Donadei E, Sarli L. Brunner’s gland hamartoma: ‘over-treatment’ of a voluminous mass simulating a malignancy of the pancreatic-duodenal area. JOP. 2005;6:348–53.Search in Google Scholar

[14] Stermer E, Elias N, Keren D, Rainis T, Goldstein O, Lavy A. Acute pancreatitis and upper gastrointestinal bleeding as presenting symptoms of duodenal Brunner’s gland hamartoma. Can J Gastroenterol. 2006;20:541–2.10.1155/2006/806926Search in Google Scholar PubMed PubMed Central

[15] Gupta V, Gupta P, Jain A. Giant Brunner’s gland adenoma of the duodenal bulb presenting with ampullary and duodenal obstruction mimicking pancreatic malignancy. JOP. 2011;12:413–9.Search in Google Scholar

[16] Bostanci H, Dikmen K, Ekinci O, Buyukkasap C, Kerem M. A case of Brunner’s gland adenoma mimicking tumors induced from head of the pancreas. Pan Afr Med J. 2018;29:78. 10.11604/pamj.2018.29.78.11502.Search in Google Scholar PubMed PubMed Central

Received: 2018-12-20
Revised: 2019-12-21
Accepted: 2020-01-29
Published Online: 2020-04-26

© 2020 Bo Yang et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Downloaded on 19.4.2024 from https://www.degruyter.com/document/doi/10.1515/biol-2020-0029/html
Scroll to top button